Better Healthcare ETF: iShares Biotechnology-Focused IBB vs. Simplify's Broad PINK
iShares offers lower fees and concentrated biotech exposure with stronger 1-year returns, while Simplify provides broader healthcare diversification and a higher dividend yield.
Overview
Investors choosing between the Simplify Health Care ETF (NYSEMKT:PINK) and iShares Biotechnology ETF (NASDAQ:IBB) must weigh the Simplify fund's active management and broader healthcare focus against the iShares fund's lower fees and concentrated biotech exposure.
The iShares Biotechnology ETF tracks a market-cap-weighted index of U.S. biotechnology stocks, offering high-conviction exposure to the sector. In contrast, the Simplify fund is an actively managed ETF targeting a wider array of medical innovation while pledging its net profits to the Susan G. Komen foundation.
Details
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Source
Originally published at www.fool.com.